Study reveals new drug therapy for leukemia patients ANI | Updated: Feb 20, 2021 23:11 IST
Washington [US], February 20 (ANI): A clinical study by the scientists of McMaster University claims to have taken an early step towards drug therapy for acute myeloid leukemiapatients.
During the research published in the Cell Reports Medicine journal, the team discovered that for acute myeloid leukemia (AML) patients, there is a dopamine receptor pathway that becomes abnormally activated in the cancer stem cells. This inspired the clinical investigation of a dopamine receptor-inhibiting drug thioridazine as a new therapy for patients, and their focus on adult AML has revealed encouraging results.
Study takes early step towards leukemia drug therapy
Study takes early step towards leukemia drug therapy
Last Updated: Wed, Feb 17th, 2021, 08:54:23hrs
Washington (US), February 17 (ANI): During recent research, an important early step in developing a new class of therapeutics has been taken by a McMaster stem cell research team for patients with deadly blood cancer.
The team has discovered that for acute myeloid leukemia (AML) patients, there is a dopamine receptor pathway that becomes abnormally activated in the cancer stem cells. This inspired the clinical investigation of a dopamine receptor-inhibiting drug thioridazine as a new therapy for patients, and their focus on adult AML has revealed encouraging results.
Study takes early step towards leukemia drug therapy aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
A clinical investigation of a dopamine receptor-inhibiting drug as a new therapy for acute myeloid leukemia (AML) patients has revealed encouraging results.